Expression of NY-ESO-1 in Triple-Negative Breast Cancer Is Associated with Tumor-Infiltrating Lymphocytes and a Good Prognosis

Publisher： Karger

E-ISSN： 1423-0232|89|6|337-344

ISSN： 0030-2414

Source： Oncology, Vol.89, Iss.6, 2015-09, pp. : 337-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predicting the level of tumor‐infiltrating lymphocytes in patients with triple‐negative breast cancer: Usefulness of breast MRI computer‐aided detection and diagnosis

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 47, Iss. 3, 2018-03 ,pp. : 760-766

John Wiley & Sons Inc

Access to resources Recommend Favorite

Triple-negative breast cancer

By Bartsch Rupert  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 7-8, 2010-04 ,pp. : 174-181

Springer Publishing Company

Access to resources Recommend Favorite

The role of the androgen receptor in triple-negative breast cancer

By Shah Payal D   Gucalp Ayca   Traina Tiffany A  

Women's Health, Vol. 9, Iss. 4, 2013-07 ,pp. : 351-360

Future Medicine

Access to resources Recommend Favorite

The Ethnic Profile of Triple-Negative Breast Cancer

By  

Oncology Research and Treatment, Vol. 31, Iss. 11, 2008-10 ,pp. : 580-582

Karger

Access to resources Recommend Favorite

Clinicopathologic and Prognostic Characteristics of Triple-Negative Breast Cancer

By  

Oncology Research and Treatment, Vol. 31, Iss. 11, 2008-10 ,pp. : 610-614

Karger

Access to resources Recommend Favorite